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ABSTRACT 
Objective: Individuals with obesity and type 2 diabetes differ from lean and healthy individuals 
in their abundance of certain gut microbial species and microbial gene richness.  Abundance of 
Akkermansia muciniphila, a mucindegrading bacterium, has been inversely associated with body 
fat mass and glucose intolerance in mice, but more evidence is needed in humans.  The impact of 
diet and weight loss on this bacterial species is unknown.  Our objective was to evaluate the 
association between fecal A. muciniphila abundance, fecal microbiome gene richness, diet, host 
characteristics, and their changes after calorie restriction (CR).  
Design: The intervention consisted of a 6week CR period followed by a 6week weight 
stabilization (WS) diet in overweight and obese adults (N=49, including 41 women).  Fecal A. 
muciniphila abundance, fecal microbial gene richness, diet and bioclinical parameters were 
measured at baseline and after CR and WS. 
Results: At baseline A. muciniphila was inversely related to fasting glucose, waisttohip ratio, 
and subcutaneous adipocyte diameter.  Subjects with higher gene richness and A. muciniphila 
abundance exhibited the healthiest metabolic status, particularly in fasting plasma glucose, 
plasma triglycerides and body fat distribution.  Individuals with higher baseline A. muciniphila 
displayed greater improvement in insulin sensitivity markers and other clinical parameters after 
CR.  These participants also experienced a reduction in A. muciniphila abundance, but it 
remained significantly higher than in individuals with lower baseline abundance.  A. muciniphila 
was associated with microbial species known to be related to health.   
Conclusion:  A. muciniphila is associated with a healthier metabolic status and better clinical 
outcomes after CR in overweight/obese adults.  The interaction between gut microbiota ecology 
and A. muciniphila warrants further investigation. 
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SUMMARY BOX:  
 
What is already known about this subject? 
• Evidence suggests that gut microbiota diversity and metabolic function plays an important 
role in the development of obesity and related metabolic disorders. 
• Dietary changes including calorie restriction can profoundly impact the gut microbiota.  
• Akkermansia muciniphila is associated with healthier glucose metabolism and leanness in 
mice but this is less conclusive in humans.  
 
What are the new findings? 
• Higher A. muciniphila abundance is associated with a healthier metabolic status in 
overweight/obese humans.  
• There is an interaction between gut microbiome richness, certain metagenomic species and A. 
muciniphila, whereby higher abundance of this species together with greater microbial gene 
richness are associated with a healthier metabolic status. 
• Higher abundance of A. muciniphila at baseline is associated with greater improvement in 
glucose homeostasis, blood lipids and body composition after calorie restriction. 
 
How might it impact on clinical practice in the foreseeable future? 
• Our findings demonstrate the need for further investigation to ascertain the therapeutic 
applicability of A. muciniphila in the treatment of insulin resistance.  
• A. muciniphila may be identified as a diagnostic or prognostic tool to predict the potential 
success of dietary interventions. 
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INTRODUCTION 
Altered gut microbiota composition and function contribute to the development of obesity 
in mice and its associated comorbidities in both mice and humans.[1–5]  There is increasing 
evidence showing interactions between environmental factors, gut microbiota, metabolic diseases 
and cardiovascular risks.[5–7]  Specific bacterial groups have been implicated in obesity and 
related metabolic diseases, and may therefore be considered as therapeutic targets.  As such, 
Akkermansia muciniphila, a mucindegrading bacterium, was proposed to be a contributor to the 
maintenance of gut health[8–10] and glucose homeostasis.[11]  We, and others, have shown in 
mouse studies a causative role for this species in lowering body fat mass, improving glucose 
homeostasis, decreasing adipose tissue inflammation, and increasing gut integrity.[12–14]  The 
latter was demonstrated following oral administration of A. muciniphila that led to increased 
mucin layer thickness, decreased metabolic endotoxemia,[12] and increased number of goblet 
cells.[13]  
In humans, the role of A. muciniphila remains ambiguous.  One study reported that A. 
muciniphila was more abundant in subjects with normal glucose tolerance compared to a pre
diabetic group.[15]  The opposite relationship was seen by others, where A. muciniphila was 
enriched in patients with type 2 diabetes (T2D) compared to nondiabetic controls.[16]  These 
two studies were conducted in lean/overweight Chinese adult populations with a wide age range.  
A third study in 70year old normal weight European women showed that A. muciniphila was not 
among the species applicable to classify women as having T2D.[17]  This discrepancy may be 
due to differences in study design, methodology, and population characteristics such as ethnicity, 
age and diet.[18]   
Studying changes in A. muciniphila after an intervention known for improving metabolic 
health offers stronger evidence of its role than measuring crosssectional relationships.  Weight 
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loss through calorie restriction (CR) or bariatric surgery has a profound effect on gut 
microbiota.[19,20]  Characteristics of the gut ecosystem, such as high microbial gene richness, 
have been associated with better cardiometabolic health and improvements in clinical 
characteristics after a dietinduced weight loss intervention.[21,22]  Limited available evidence 
suggests that A. muciniphila increases with bariatric surgery in both humans and mice,[23–26] 
but there is no evidence on the effects of CR. 
We have previously published results from this dietary intervention,[21,27] where 
overweight and obese individuals underwent weight loss through CR followed by weight 
stabilization (WS).  In the same cohort, we herein aim to evaluate the potential associations 
between A. muciniphila with microbial gene richness, diet, host anthropometric and metabolic 
parameters, and further address their changes after the intervention. 
 
MATERIALS AND METHODS 
Study population 
This dietary intervention was conducted at the Institute of Cardiometabolism and 
Nutrition (ICAN), PitiéSalpêtrière Hospital in Paris, France.  The 49 participants were 
overweight (N=11) or obese (N=38) (male:female = 8:41), and have been previously described in 
detail.[21,27]  A smaller sample size has been specified when there is missing data.  Briefly, 
subjects had no diabetes, chronic or inflammatory diseases.  No antibiotics were taken for 2 
months before stool collection.  Details of the dietary intervention, which consisted of a 6week 
CR diet enriched with fibers and protein followed by a 6week WS period have been previously 
described.[27]  The study was reviewed and authorized by the Ethical Committee (CPP N°1 
Hôtel Dieu Hospital) and all participants signed an informed consent. The study has been 
registered on clinicaltrials.gov: NCT01314690. 
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Body composition and biochemical parameters 
Anthropometric measurements included BMI, waist and hip circumference and their ratio 
(WHR).  Total body fat, fat free mass, gynoid and android fat proportions were determined using 
dual energy xray absorptiometry (DXA), as previously described.[28] 
Blood samples were collected after a 12hour fast at baseline, week 6 and 12.  
Measurements included blood lipids, namely nonesterified fatty acids (NEFA), triglycerides 
(TG), total, LDL and HDLcholesterol.  Inflammatory and endotoxemia markers included high 
sensitivity Creactive protein (hs CRP), interleukin6 (IL6)[29] and lipopolysaccharide 
(LPS),[30] as described previously.[27]  Aspartate transaminase (AST), alanine transaminase 
(ALT) and gammaglutamyl transpeptidase (GGT) were measured as part of a clinical blood 
panel (laboratoryestablished normal ranges: 2032 IU/L, 2035 IU/L, and 836 IU/L, 
respectively). 
The Homeostasis Model Assessment of Insulin Resistance Index (HOMAIR) was 
calculated using the HOMA2Calculator developed by Levy et al, which uses mathematical 
modeling and a healthy reference population to determine insulin sensitivity.[31]  Glucose and 
insulin AUC from the oral glucose tolerance test (OGTT) were calculated, and the Disse 
index[32] was derived using the formula:   = 12			 
	2.5			  	 −  −
 !           
Adipocyte morphology and adipose tissue macrophages  
Subcutaneous white adipose tissue (scWAT) samples were obtained at baseline, week 6 
and 12 by needle biopsy from the periumbilical region under local anesthesia.[33]  Adipocyte 
diameter was quantified as previously described.[34]  Adipocyte morphology in relation to fat 
mass was measured using the curve fitting model developed by Spalding et al to describe 
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associations between adipocyte volume, number and body fat.[35,36]  The formula with re
estimated parameters is: 
 "ℎ$%&'(!	)*$'+&	,$! -	.*!/ = 	 (40.7 * Kg Fat Mass) 
(1 + (0.025 * Kg Fat Mass)
    
Observed adipocyte volume[37] was calculated with the formula:  
01%,)	)*$'+&	,$! -	.*!/ = [ 345678 		.)*$'+&	(-&%, μ-/
;]   
HAM56 was measured as a marker of scWAT macrophages with monoclonal antibody 
(DakoCytomation).  HAM56 positive cells were quantified as a percentage of total adipocyte 
number.[38]  
Metabolic phenotyping of serum by 
1
H NMR spectroscopy.  
Serum samples were prepared and analysed on a NMR spectrometer (Bruker) operating at 
600.22 MHz 
1
H frequency as previously described,[39] using 350 µL of sample mixed with 350 
µL of buffer before centrifugation at 12000g at 4°C for 5 min. The 
1
H NMR spectra were pre
processed and metabolic signals were recovered using statistical recoupling of variables 
(SRV).[40]  
Fecal microbiota 
A quantitative metagenomics (QM) approach was used to characterize the fecal 
microbiota with high resolution.  Briefly, highthroughput SOLiD sequencing was performed on 
total fecal DNA as described in Cotillard et al.[21]  Reads were mapped and counted onto the 3.9 
million gene catalog,[41] after cleaning for quality, human, plant and cow origin using the 
Meteor Studio platform.  The metagenomic species (MGS) catalog published by Nielsen et al was 
used to cluster gene profiles in the current study.  We used the Le Chatelier et al[22] 
methodology implemented in the MetaOMineR pipeline to compute MGS tracer profiles, where 
we calculated the mean of the 50 most correlated bacterial genes after filtering at 20% presence 
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and used only large MGS with more than 500 genes to focus on potential bacterial species. The 
taxonomic annotation is an updated version of the published dataset.  The methodology for 
stratification as a function of gene richness (low gene count, LGC and high gene count = HGC) 
was as formerly described and is based on the first metagenomics catalog.[21,22] 
A. muciniphila quantification 
A. muciniphila was quantified with qPCR as described in Everard et al.[12]  Briefly, DNA 
was extracted from fecal samples,[27] and qPCR (Applied Biosystems) was done using the 16S 
rRNA primers for A. muciniphila detection and amplification: forward 
CAGCACGTGAAGGTGGGGAC, and reverse CCTTGCGGTTGGCTTCAGAT.  Total 16S 
rRNA was also quantified and used to normalize A. muciniphila using bacterial universal 
primers: forward ACTCCTACGGGAGGCAGCAG, and reverse ATTACCGCGGCTGCTGG.  
Each assay was performed in duplicate.  The cycle threshold of each sample was then compared 
with a standard curve (performed in triplicate) made by diluting genomic DNA (fivefold serial 
dilution) (DSMZ).   
A. muciniphila was also quantified using QM (GU:154), as some of the analysis included 
direct comparisons between qPCR and QM data, and good agreement was found between the two 
methods (Supplementary Figure 1 and 2).   
Diet Mean Adequacy Ratio (MAR) 
Diet was assessed with 7day unweighted food records completed just before baseline, 
week 6 and 12, as previously described.[34]  We used the Mean Adequacy Ratio (MAR) as an 
indicator of global nutrient adequacy of the diet.[42,43]  The MAR is the mean nutrient adequacy 
ratio (NAR) for 16 nutrients (proteins, fiber, retinol equivalents, thiamine, riboflavin, niacin, 
vitamin B6, folates, vitamin B12, ascorbic acid, vitamin D, vitamin E, calcium, potassium, iron 
and magnesium).  Each NAR was calculated as the mean intake of a nutrient divided by the 
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French Recommended Dietary Allowance[44] and multiplied by 100.  To avoid compensation of 
high intake of one nutrient for low intake of another, each NAR was truncated at 100.  The MAR 
ranges from 0 to 100; the higher the score, the better global nutrient adequacy of the diet. 
Bayesian network 
A Bayesian network was constructed in order to simultaneously study associations 
between relevant variables and A. muciniphila qPCR abundance.  Bayesian networks are 
probabilistic graphical models used to represent complex associations.  The variables are the 
vertices in the graph, and the edges are the direct dependencies between them.  We applied the 
Hill Climbing algorithm, which belongs to a family of local search techniques that performs a 
heuristic search based on scoring metrics.  The Bayesian Information Criterion (BIC) was used as 
a scoring function.  These procedures were conducted using the bnlearn R package, version 
3.6.[45]  
Statistical analysis  
Normally distributed data were analyzed using parametric tests (paired t test and 
ANCOVA with age and sex as covariates).  For variables with a skewed distribution or when 
conducting analysis of groups with small sample size (i.e. Akk LO/HI vs. LGC/HGC) non
parametric tests were conducted (Wilcoxon rank sum test, or KruskalWallis followed by 
multiple signed rank sum tests for individual comparisons with Bonferroni correction).  
Spearman analysis was used to determine correlation between variables.  Values in tables are 
reported as mean (SE), or adjusted mean (SE) in the case of ANCOVA.  In figures data are 
reported as box plots or as means or adjusted means ± SE.  Statistical significance was set as 
alpha=0.05, except in post hoc analysis with Bonferroni correction.  OGTT curve analysis was 
done using repeated measures ANOVA.  Microbiome analyses were performed using the 
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MetaOMineR package (Prifti and Le Chatelier, in preparation). SAS 9.3 for Windows (SAS 
Institute, Cary, NC) and R was used for all statistical analyses. 
 
RESULTS 
Baseline comparison between Akk LO and Akk HI groups 
 A. muciniphila is associated with a healthier metabolic status 
The log10 transformed A. muciniphila was normalized to log10 total bacterial content and 
we refer to this measurement as A. muciniphila.  There was no difference in fecal A. muciniphila 
abundance between overweight and obese subjects (2.57 ± 2.18 and 2.38 ± 1.72, p=0.97, 
respectively).  A. muciniphila abundance had a bimodal distribution, consistent with that seen in 
QM (Supplementary Figure 1).  Therefore, baseline A. muciniphila abundance was categorized 
around the baseline median and groups were defined as having lower (Akk LO, abundance < 
median, N=24) or higher abundance (Akk HI, abundance ≥ median, N=25).  Sex and average age 
did not differ between Akk LO and Akk HI groups (Table 1).  However, there was a higher 
number of younger subjects (age ≤ median, AgeLO, N=17) in the Akk HI group than older 
subjects (age > median, Age HI, N=8).  Further analyses were subsequently adjusted by age and 
sex.  
Subjects in the Akk HI group had a healthier metabolic status, as shown by a lower WHR, 
leptin and surrogates of insulin sensitivity (Table 1).  The Akk HI group had lower fasting blood 
glucose and insulin.  Fasting blood glucose was inversely associated with A. muciniphila 
(Supplementary Figure 3).  Both HOMAIR and Disse index suggested higher insulin 
sensitivity in Akk HI compared to Akk LO (Table 1 and Figure 1A).  Furthermore, there was an 
inverse association between glucose AUC during OGTT and A. muciniphila abundance (Figure 
1C).  Glycaemia at T15 and T60 were significantly higher in Akk LO.  Both AST and GGT were 
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lower in the Akk HI group and average values were in the normal range while they were elevated 
in Akk LO patients (Table 1). 
A. muciniphila is inversely associated with adipocyte size 
ScWAT Adipocyte diameter, but not total fat mass, was inversely associated with A. 
muciniphila abundance (Figure 2A and B), and Akk HI had lower mean adipocyte size (Table 
1).  When fitting the formula developed by Spalding et al to describe the association between 
adipocyte volume and fat mass[35] the Akk HI group tended to fall below the theoretical curve 
(Figure 2C) as quantified in a residual plot (Figure 2D), suggesting increased adipocyte 
hyperplasia in Akk HI subjects.     
Signature associated with A. muciniphila abundance 
To study associations between relevant variables simultaneously at baseline, and examine 
the strongest associations with A. muciniphila abundance, a Bayesian network was built (Figure 
1B).  Corroborating the observations from the univariate analysis, the clinical factors most 
dependent (d) with baseline A. muciniphila abundance are fasting glucose (d=0.86), HOMAIR 
(d=0.66) and mean adipocyte diameter (d=0.84). 
Changes with calorie restriction intervention 
Akk HI group had greatest benefits from the dietary intervention 
There was no difference in weight loss between the Akk HI and LO groups (data not 
shown).  While there was a decrease in A. muciniphila abundance in the Akk HI group after CR 
and the total intervention period, it remained consistently and significantly higher than the Akk 
LO group (more than 100 times difference, Figure 3A and Supplementary Figure 3), although 
the range of abundance became more spread out after CR and WS in both groups 
(Supplementary Figure 4A).  The change in A. muciniphila abundance was different between 
the two groups after CR and the 12week period (Figure 3B).  The Akk HI group remained 
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metabolically healthier throughout the dietary intervention, with a tendency for a higher Disse 
index after CR and WS (Figure 4A and E), a greater improvement of total and LDL cholesterol 
after CR and total intervention period (Figure 4C, D and G, H), and a continued decrease in WC 
during the WS period (Figure 4B and F).   
Serum acetate correlates with A. muciniphila at baseline 
A. muciniphila is a producer of SCFA, primarily acetate and propionate.[46,47]  The latter 
is not usually detectable in serum by 
1
H NMR spectroscopy, but serum acetate was positively 
correlated with A. muciniphila abundance (Figure 5A).  There was a reduction in serum acetate 
throughout the dietary intervention in the total population as well as the Akk LO and HI groups.  
Although it remained higher in Akk HI group, the difference in variation in serum acetate 
concentrations did not reach significance when compared between groups (Figure 5B and C).  
A. muciniphila and the microbial ecosystem 
It is likely that the association between fecal microbiota and health indicators is not 
attributable to a single microbe, but rather to an ecosystem that influences the complicated 
interaction between host biology and environment.  As such, we studied A. muciniphila 
abundance in relation to the microbiomewide MGS abundance and microbial gene richness. 
A. muciniphila and MGS abundance 
There were 27 large MGS (> 500 genes) associated with A. muciniphila abundance 
throughout the intervention (p<0.01, including the A. muciniphila MGS, 13 Firmicutes, 5 
Bacteroidetes, 1 Actinobacteria and 1 Euryarchaeota) (Figure 6A).  Nineteen of these MGS 
(70%) were more abundant in the Akk HI group.  Some of the 26 MGS remained associated with 
A. muciniphila abundance throughout the intervention, while for others this association was lost 
at week 6, or lost and then regained at week 12.  These 26 MGS represented less than 20% of the 
microbiome at all times when considering the large MGS as a reference (Figure 6B). 
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Individuals with higher A. muciniphila and gene richness have healthiest metabolic profile 
We previously reported that high fecal gene richness was associated not only with 
healthier baseline metabolic status but also with better outcomes from the dietary 
intervention.[21]  We therefore studied the relationship between A. muciniphila abundance and 
bioclinical parameters in the context of gene richness, leading to the definition of four groups: 
Akk LO, LGC; Akk HI, LGC; Akk LO, HGC; and Akk HI, HGC.  The Akk HI, HGC group had 
the best metabolic status with the lowest median % android fat, fasting glucose and triglycerides, 
and the highest median % gynoid fat (Figure 7A-D).  Most importantly, after the CR and WS 
phases, this group remained metabolically healthier (Supplementary Figure 5).  Linear 
regression analysis showed that the interaction term had the largest effect size for body fat 
distribution and triglycerides, while Akk LO/HI had the biggest effect size for glucose 
(Supplementary Table 1).  
A. muciniphila and dietary intake 
At baseline, dietary intake did not greatly differ between the Akk LO and HI groups.  
However, age was identified as a confounder for diet, with older subjects having a healthier diet 
than younger subjects, i.e. higher consumption of dairy products, fruits and vegetables and fish, 
and lower consumption of sugary drinks.[48]  There were no significant differences in the 16 
NARs and the MAR between the Akk LO and HI groups (Figure 8A and Supplementary Table 
2), but older subjects tended to have higher NARs of several nutrients (data not shown) and had a 
significantly higher MAR than younger subjects (Figure 8B).  During the WS period, older 
subjects experienced a greater increase in MAR (Figure 8D). 
When studying the change in MAR, there was no difference in diet quality between Akk 
LO and Akk HI at any time point (Figure 8A and Supplementary Table 2).  These results did 
not change after adjustment for total energy intake.  As expected, in either categorization (age or 
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A. muciniphila abundance) MAR significantly decreased during the CR period and increased 
after the WS period. 
 
DISCUSSION  
We herein show in overweight and obese individuals that higher A. muciniphila 
abundance is associated with a healthier metabolic status, particularly with higher insulin 
sensitivity at baseline and improvement after CR and WS, thus confirming in humans what had 
been observed in murine models.[12–14]  Subjects with higher A. muciniphila and gene richness 
are metabolically healthier before and after the dietary intervention, thus demonstrating an 
interaction between gut bacterial richness and A. muciniphila abundance. 
Murine studies showed not only a positive correlation between A. muciniphila and health, 
but established causality, where induced A. muciniphila expansion led to improved 
metabolism[12–14].  Our results show an association between A. muciniphila and a healthier 
insulin sensitivity profile, and indicate that higher A. muciniphila abundance is linked to better 
outcomes after weight loss through CR.  Importantly, A. muciniphila abundance in the Akk HI 
group remained approximately 100 times higher than in the Akk LO group throughout the 
intervention even if there was an intriguing reduction in the Akk HI group (Figure 3).  We 
suggest that there may be a range of A. muciniphila abundance associated with a healthier 
metabolic status and better outcomes after CR.   
Adipocyte hypertrophy is associated with chronic proinflammatory cytokine 
secretion[49] and greater risk for insulin resistance.[36]  Adipocyte diameter, glucose and 
surrogates of insulin sensitivity appear tightly linked with A. muciniphila in the Bayesian network 
(Figure 1B).  Primary defects in glucose homeostasis were observed at fasting and during early 
OGTT time points, which reflect more hepatic insulin sensitivity, rather than peripheral glucose 
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disposal.[50,51]  Therefore, our results suggest that the glucose homeostatic defect in Akk LO 
individuals is primarily hepatic.  In line with this, hepatic biology was solely impaired in Akk LO 
patients (Table 1).  Clamp studies are needed to validate this hypothesis more precisely. 
A. muciniphila produces a variety of fermentation products, including SCFA, through 
mucin degradation.  These substrates may serve as energy sources both for other bacteria and the 
host.[46]  It is possible that through this crossfeeding[18] A. muciniphila may contribute to the 
expansion of other beneficial species, while it may itself have a direct effect on host metabolism, 
consistent with rodent studies.[12]  Serum SCFA analysis showed an association between A. 
muciniphila abundance and acetate at baseline.  Acetate plays a role in prevention of weight gain 
through an anorectic effect, inflammation, metabolic dysregulation, and it is the most 
predominant gutproduced SCFA in peripheral blood.[52,53]  However, it is unclear to what 
extent A. muciniphila contributes to circulating acetate.  Indeed, while there is a strong 
correlation between A. muciniphila abundance and serum acetate concentration at baseline, this 
was not maintained throughout the dietary intervention. 
Our results shed new light on the relationship between A. muciniphila, the gut ecosystem, 
and host health.  The healthiest metabolic status was seen in subjects with higher A. muciniphila 
abundance in the context of greater bacterial gene richness in this French population.  A. 
muciniphila was also found more abundant in HGC individuals in a Danish population.[22]  
Furthermore, we show that A. muciniphila was associated with 26 MGS, which represent up to 
20% of the microbiome.  Of interest, one of these MGS is Methanobrevibacter smithii, believed 
to be a producer of mucinlike glycans, as proposed by [54], while an association with mucin
degrader Ruminococcaceae was also observed.  The latter was increased in abundance when 
NOD mice, which spontaneously develop type1 diabetes, were fed a diabetesprotective 
diet.[55] 
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In a study where germ free mice with or without A. muciniphila gavage were infected 
with Salmonella typhimurium, the presence of A. muciniphila exacerbated the infection,[56] 
which suggested that the effect of an unregulated growth of A. muciniphila without competition 
from other species led to a deleterious modification of the gut environment and thinning of the 
mucosal layer, enabling the infection.  Conversely, a recent study shows in vitro that A. 
muciniphila may adhere to the intestinal epithelial cells, thereby contributing to strengthen the 
monolayer integrity.[57] 
Dietary patterns influence gut microbiota diversity, although little is known about the 
effect of diet on A. muciniphila.[18,58]  Consumption of various types of dietary fiber has 
yielded different results: an increase of A. muciniphila with oligofructose [12,59] and fermentable 
oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet,[60] but a 
decrease with pectin or guar gum when compared to mice fed a fiberfree diet.[61].  We did not 
observe significant differences in baseline nutrient intake between Akk groups.  Even though 
subjects increased consumption of fiber (particularly inulintype fructans) during CR, this study 
design prevents us from reaching conclusions regarding A. muciniphila and diet.  We can 
conclude, however, that the Akk HI group experienced greater metabolic improvement than Akk 
LO, while there was no difference between groups in weight loss, or MAR score.  However, 
since MAR does not include saturated fats, sodium, or simple sugars intakes it is not a complete 
diet quality indicator.  Studies specifically designed to assess the effect of diet, particularly fiber 
intake, on A. muciniphila abundance in a population homogenous in age and health status are 
warranted.  
The relatively narrow range of glucose intolerance phenotype in this population 
constitutes a limitation of this study.  Further investigation should focus on more diverse 
populations ranging from lean healthy to glucose intolerance or insulin resistance to overt T2D.  
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Even though we have shown that higher baseline A. muciniphila abundance is associated with 
better clinical outcomes after CR, and literature suggests an increased abundance of A. 
muciniphila after gastric bypass,[23–26] a direct comparison between the effect of energy 
restriction versus bariatric surgery should also be implemented to establish a link between energy 
restriction, nutrient malabsorption, A. muciniphila modifications, and improved glucose 
metabolism. 
From the present study we cannot conclude whether fecal bacterial abundance is directly 
proportional to abundance in the gut.  Microbiota in the mucus layer differs from that of the 
intestinal lumen,[62] and A. muciniphila is closely associated to the gut mucosal layer.  The 
observed differences in abundance of A. muciniphila into feces may be due to actual changes in 
bacterial numbers, or alterations of the mucosal layer and gut architecture.  Host genetics, may 
also play a role in how dietary interventions influence gut microbiota and metabolic health, as 
previously shown in mice, where different strains had notably different gut microbial 
composition and intestinal environment that correlated with a variety of cardiometabolic 
profiles.[63]  The host’s innate and adaptive immune system may also influence the composition 
of gut microbiota.[64]  A recent study showed greater prevalence of A. muciniphila in the 
absence of pressure from the adaptive immune system in Rag1(/) immunodeficient mice.[65]  
Furthermore, while dietary interventions have been proven to greatly impact gut microbiota 
characteristics,[19,20] the stability of gut microbiota modifications after a dietary intervention 
needs to be assessed to verify whether gut microbiota changes are related to the maintenance of 
metabolic benefits over time.  In conclusion, we demonstrated a significant association between 
A. muciniphila abundance and metabolic health and we provide a first view of A. muciniphila 
association with the gut ecosystem.  Collectively, these observations demonstrate the importance 
of studying A. muciniphila in the context of the gut environment, as it may drive a favorable or 
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deleterious contribution of A. muciniphila to health. The underlying mechanisms explaining these 
associations should be investigated in future studies.  
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TABLES 
Table 1. Comparison between clinical variables categorized into A. muciniphila abundance 
groups. 
      
Akk LO 
(N=24) 
Akk HI 
(N=25) 
p-
value 
 
Sex, N(%) F 19 (79.2) 22 (88.0) 
0.4 
  
M 5 (20.8) 3 (12.0) 
 
Age (y) 
 
45 (12) 39 (12) 0.18 
 Age categorization around the 
median, N(%) 
Age LO (≤ 
49 y) 
8 (32.0) 17 (68.0) 
0.02 
  
Age HI (> 
49 y) 
16 (66.7) 8 (33.3) 
Body 
composition 
BMI (kg/m
2
)   33.0 (0.9) 32.5 (1.0) 0.63 
Waist circumference (cm) 
 
108.8 (2.2) 105.7 (2.3) 0.27 
Hip circumference (cm) 
 
113.4 (2.0) 115.0 (2.1) 0.51 
WHR 
 
0.96 (0.01) 0.92 (0.02) 0.04 
Fat mass (%) 
 
35.6 (1.0) 34.2 (1.1) 0.30 
Lean mass (%) 
 
61.5 (1.0) 62.7 (1.1) 0.33 
% of android fat (DXA) 
 
61.1 (1.3) 59.5 (1.4) 0.33 
% of gynoid fat (DXA) 
 
36.3 (1.3) 37.6 (1.4) 0.42 
Adipocyte Diameter (µm)   111.5 (1.6) 104.8 (1.8) 0.002 
Glucose 
homeostasis 
Glucose (mmol/L)   5.4 (0.1) 5.2 (0.1) 0.02 
Insulin (µIU/ml ) 
 
11.3 (0.9) 8.9 (0.9) 0.03 
HOMAIR 
 
1.5 (0.1) 1.2 (0.1) 0.03 
Disse index 
 
9.2 (1.0) 6.0 (1.1) 0.02 
 
Alanine transaminase (ALT) 
(IU/L)  
38.2 (3.3) 31.5 (3.5) 0.11 
Liver 
enzymes 
Aspartate transaminase (AST) 
(IU/L)  
39.5 (3.7) 29.0 (3.9) 0.03 
 
Gammaglutamyl 
transpeptidase (GGT) (IU/L)  
57.0 (5.6) 35.3 (6.0) 0.004 
Blood 
lipids 
LDLc (mmol/L) 
 
3.4 (0.2) 3.3 (0.2) 0.66 
Triglycerides (mmol/L) 
 
1.2 (0.9  1.7) 1.0 (0.8  1.2) 0.08 
Nonesterified fatty acids 
(NEFA) (mmol/L) 
  0.42 (0.04) 0.41 (0.04) 0.76 
Systemic 
inflammation 
hs CRP (mg/L)   4.6 (1.7  7.2) 2.4 (0.9  6.9) 0.11 
IL6 (pg/ml) 
 
1.3 (0.7  2.9) 1.6 (1.1  2.3) 0.93 
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LPS (pg/ml) 
 
1.7 (1.2  2.7) 2.1 (1.2  2.9) 0.80 
scWAT 
macrophage 
markers 
HAM56 (%)   13.6 (8.2  22.9) 
10.0 (6.5  
17.5) 
0.18 
%HAM56 / Adipocyte 
Diameter  
0.13 (0.02) 0.10 (0.02) 0.23 
Adipokines 
Leptin (ng/ml)   44.1 (3.6) 30.9 (3.9) 0.005 
Adiponectin (µg/ml)   15.1 (5.9  20.0) 
14.7 (11.5  
17.4) 
0.77 
For variables with a skewed distribution (triglycerides, CRP, IL6, LPS, %HAM56 and 
adiponectin):  Wilcoxon rank sum test, median (Q1Q3) shown.  For other variables: ANCOVA 
adjusting for age and sex, adjusted mean (SE) shown. Akk LO = A. muciniphila below the 
median; Akk HI = A. muciniphila at or above the median. 
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FIGURE LEGENDS 
Figure 1.  Association between A. muciniphila abundance and markers of insulin sensitivity. 
A: Comparison of fasting glucose, insulin, HOMAIR and Disse index between Akk LO and Akk 
HI groups.  B: Bayesian network showing the dependencies between variables selected based on 
their association with A. muciniphila.  The thickness of the edges connecting the vertices 
(variables) represents the weight of dependencies between variables.  Akk = A. muciniphila, 
WHR = waisttohip ratio, Adip_Diam = adipocyte diameter, TG = triglycerides, Chol = total 
cholesterol, HOMAIR = Homeostasis Model Assessment of Insulin Resistance Index, Disse = 
Disse index, AST = aspartate transaminase, ALT = alanine transaminase, GGT = gamma
glutamyl transpeptidase.  C and D: OGTT glucose and insulin curves, respectively (included 
times: 0, 15, 30, 60, 90, and 120 minutes), with comparison in glucose AUC between Akk LO 
(N=18) and Akk HI (N=22) by ANCOVA adjusting for age and sex.  Spearman correlation 
between glucose or insulin AUC and A. muciniphila abundance is shown.  Akk LO = A. 
muciniphila below the median; Akk HI = A. muciniphila at or above the median. 
 
Figure 2. Relationship between adipocyte volume and body fat mass according to A. 
muciniphila groups. 
A: Spearman correlation between A. muciniphila and kg fat mass.  B: Spearman correlation 
between A. muciniphila and adipocyte diameter.  C: Association between adipocyte volume and 
body fat mass in relation to fitted curve, with black circles representing the Akk HI group and 
white circles the Akk LO group.  D: Residuals of data points in part C.  Akk LO = A. muciniphila 
below the median; Akk HI = A. muciniphila at or above the median. 
 
Figure 3. Changes in A. muciniphila abundance with dietary intervention.  
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A: Paired t test was used to measure the withingroup change in A. muciniphila abundance, mean 
(SE) is shown; *p<0.05 with paired t test; #p<0.01, ##p<0.001 and ###p≤0.0001 with t test 
between Akk LO and HI at each time point.  B: ANCOVA adjusting for age and sex was used to 
compare the change between Akk LO and Akk HI groups, adjusted mean change (SE) is shown; 
p<0.05.  CR=calorie restriction; WS=weight stabilization; Akk LO = A. muciniphila below the 
median; Akk HI = A. muciniphila at or above the median. 
 
Figure 4. Comparing the effect of dietary intervention on bioclinical parameters between A. 
muciniphila groups.    
A-D: Paired t test was used to measure the withingroup change in Disse index (A), waist 
circumference (B), and total and LDL cholesterol (C, D); mean (SE) is shown.  E-H: ANCOVA 
adjusting for sex, age and baseline value was used to compare the change between Akk LO and 
Akk HI groups in Disse index (E), waist circumference (F), and total and LDL cholesterol (GH); 
adjusted mean change (SE) is shown.  *p≤0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001; 
CR=calorie restriction; WS=weight stabilization; Total = T0 to W12. Akk LO = A. muciniphila 
below the median (gray bars and lines); Akk HI = A. muciniphila at or above the median (black 
bars and lines). 
 
Figure 5.  Serum acetate and A. muciniphila. 
A: Spearman correlation between serum acetate and A. muciniphila abundance.  B: Withingroup 
change in serum acetate assessed by paired t test, mean (SE) shown, * p≤0.05.  C: Comparison of 
change in serum acetate between Akk groups, mean (SE) shown; t test.  Akk LO = A. muciniphila 
below the median; Akk HI = A. muciniphila at or above the median. 
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Figure 6.  Association between A. muciniphila and metagenomic species  
A: Barcodes indicating the presence and abundance of the MGS that are significantly abundant 
between Akk LO and Akk HI (Wilcoxon p<0.01) in a given time point.  White is absent and 
abundance increases from light blue to dark red.  Samples are sorted by A. muciniphila baseline 
abundance.  Green text indicates MGS that are more abundant in the Akk HI group at baseline 
and in brown in the Akk LO group.  Pvalues in red indicate MGS that are correlated with gene 
richness; # significant qvalue; ‘ p<0.05; * p<0.01.  B: Cumulative abundance load of the A. 
muciniphila MGS (red) and the 26 associated MGS (yellow) compared to the rest of the MGS 
(with more than 500 genes) in gray. 
 
Figure 7.  Clinical parameters that differ across A. muciniphila and gene richness groups.  
A. muciniphila x gene count groups were compared: A: % android fat; B: % gynoid fat; C: 
fasting plasma glucose; and D: fasting plasma triglycerides.  Akk LO = A. muciniphila below the 
median; Akk HI = A. muciniphila at or above the median; HGC = high gene count; LGC = low 
gene count.  KruskalWallis followed by Wilcoxon Rank Sum test for individual comparisons 
with Bonferroni adjustment. Sample sizes are Akk LO, LGC N=9; Akk HI, LGC N=9; Akk LO, 
HGC N=11; Akk HI, HGC N=16 (p=0.56, Fisher’s Exact test). 
 
Figure 8. Change in MAR diet quality score by A. muciniphila abundance and age over the 
different stages of the dietary intervention. 
A-B: Paired t test was used to measure the withingroup change in MAR.  C: ANCOVA 
adjusting for age, sex and baseline MAR value was used to compare the change between Akk 
categories.  D: ANCOVA adjusting for sex and baseline MAR value was used to compare the 
change between age categories.  In AB mean (SE), and in CD adjusted mean change (SE) is 
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shown.  *p≤0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001.  CR=calorie restriction; WS=weight 
stabilization.  Akk LO = A. muciniphila below the median, N=15; Akk HI = A. muciniphila at or 
above the median, N=21. Age LO = Age below population median, N=18; Age HI = Age at or 
above the population median, N=18. 
 
Supplementary Figure 1.  A. muciniphila abundance distribution comparison between 
qPCR and QM. 
 
Supplementary Figure 2.  Comparison of changes in A. muciniphila abundance throughout 
dietary intervention between qPCR and QM.  
 
Supplementary Figure 3.  Correlation matrix depicting the baseline association between 
relevant variables. 
 
Supplementary Figure 4.  Individual variations in A. muciniphila abundance and fasting 
glucose throughout the dietary intervention.   
A: A. muciniphila individual kinetics.  B: Fasting glucose individual kinetics. 
 
Supplementary Figure 5.  Clinical parameters that differed across A. muciniphila and gene 
count groups at different time points.   
KruskalWallis for trend followed by Wilcoxon Rank Sum test for individual comparisons with 
Bonferroni adjustment.  Akk LO = A. muciniphila below the median; Akk HI = A. muciniphila at 
or above the median; HGC = high gene count; LGC = low gene count.  Sample sizes are Akk LO, 
LGC N=9; Akk HI, LGC N=9; Akk LO, HGC N=11; Akk HI, HGC N=16. 
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Supplementary Table 1.  Effect size of A. muciniphila abundance and gene richness on 
clinical parameters.   
 Effect size (%) 
Outcome Akk 
(LO/HI) 
Gene richness 
(LGC/HGC) 
Interaction 
% Android fat 4.1% 0% 15.7% 
% Gynoid fat 3.5% 0% 14.8% 
Glucose 15% 0% 12.5% 
Triglycerides 2.8% 4.2% 7.5% 
Effect size is the adjusted R2 from linear regression models. 
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Supplementary Table 2.  Comparison of NARs at T0, W6 and W12 between Akk LO and 
HI groups.   
    Akk LO (N=15) Akk HI (N=21)   
Time Point NAR Mean Std Dev Mean Std Dev p-value 
Baseline 
Protein 100 0 97 10 24 
Fiber 64 23 52 17 8 
Vitamin A 55 32 52 25 82 
Thiamine 81 18 85 16 45 
Riboflavin 80 20 80 20 81 
Niacin 99 4 91 16 21 
Vitamin B6 87 16 79 21 26 
Folic acid 78 23 75 21 58 
Vitamin B12 95 9 93 18 45 
Vitamin C 71 27 75 28 58 
Vitamin D 27 14 43 27 11 
Vitamin E 66 26 66 22 99 
Iron 67 20 65 21 95 
Magnesium 61 17 61 13 85 
Potassium 79 17 81 18 80 
Calcium 70 28 76 24 50 
Week 6 
Protein 100 0 100 0 100 
Fiber 82 15 73 24 37 
Vitamin A 16 24 7 5 24 
Thiamine 61 16 58 21 75 
Riboflavin 63 17 67 24 70 
Niacin 85 18 81 20 79 
Vitamin B6 73 18 72 19 91 
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Folic acid 72 17 76 25 45 
Vitamin B12 81 19 72 27 28 
Vitamin C 86 19 85 25 40 
Vitamin D 20 23 23 29 55 
Vitamin E 58 26 59 25 85 
Iron 49 15 48 25 36 
Magnesium 49 8 49 20 40 
Potassium 81 16 79 19 97 
Calcium 65 18 69 28 40 
Week 12 
Protein 100 1 99 3 79 
Fiber 73 17 62 26 17 
Vitamin A 43 27 35 16 61 
Thiamine 82 20 90 13 38 
Riboflavin 84 16 86 17 32 
Niacin 95 10 97 9 52 
Vitamin B6 85 21 88 15 84 
Folic acid 87 21 81 21 51 
Vitamin B12 86 24 93 13 61 
Vitamin C 86 23 81 20 39 
Vitamin D 34 30 27 16 100 
Vitamin E 59 27 57 13 50 
Iron 64 17 62 19 54 
Magnesium 61 9 62 17 97 
Potassium 89 14 82 17 31 
Calcium 75 22 82 22 32 
Wilcoxon rank sum test, mean (SD) are shown.  The NAR is the mean intake of a nutrient 
divided by the French Recommended Dietary Allowance, and truncated at 100. 
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